Seeking Alpha

Eli Lilly (LLY -1.8%) says it's received a positive opinion from the Committee for Medicinal...

Eli Lilly (LLY -1.8%) says it's received a positive opinion from the Committee for Medicinal Products for Human Use in Europe recommending approval of Amyvid, a solution for injection as a diagnostic radiopharmaceutical in the brains of adult patients being evaluated for Alzheimer's Disease and other causes of cognitive impairment.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|